Binocular Visual Rehabilitation in Paralytic Strabismus by Botulinum A Toxin Chemodenervation

CONCLUSION: BTXA chemodenervation reduced the angle of deviation and the number of patients with diplopia regardless of the cause of paralytic strabismus. Early BTXA chemodenervation can be considered as the first treatment of choice in paralytic strabismus, especially in esotropia patients.PMID:34823346 | DOI:10.3341/kjo.2021.0054
Source: Korean Journal of Ophthalmology : KJO - Category: Opthalmology Authors: Source Type: research